237 related articles for article (PubMed ID: 9870466)
1. Reduced binding of immunoglobulin A (IgA) from patients with primary IgA nephropathy to the myeloid IgA Fc-receptor, CD89.
van Zandbergen G; van Kooten C; Mohamad NK; Reterink TJ; de Fijter JW; van de Winkel JG; Daha MR
Nephrol Dial Transplant; 1998 Dec; 13(12):3058-64. PubMed ID: 9870466
[TBL] [Abstract][Full Text] [Related]
2. Complexes of IgA with FcalphaRI/CD89 are not specific for primary IgA nephropathy.
van der Boog PJ; De Fijter JW; Van Kooten C; Van Der Holst R; Van Seggelen A; Van Es LA; Daha MR
Kidney Int; 2003 Feb; 63(2):514-21. PubMed ID: 12631116
[TBL] [Abstract][Full Text] [Related]
3. Identification of a novel Fcalpha receptor expressed by human mesangial cells.
Barratt J; Greer MR; Pawluczyk IZ; Allen AC; Bailey EM; Buck KS; Feehally J
Kidney Int; 2000 May; 57(5):1936-48. PubMed ID: 10792612
[TBL] [Abstract][Full Text] [Related]
4. Critical Role of Kupffer Cell CD89 Expression in Experimental IgA Nephropathy.
Xu L; Li B; Huang M; Xie K; Li D; Li Y; Gu H; Fang J
PLoS One; 2016; 11(7):e0159426. PubMed ID: 27437939
[TBL] [Abstract][Full Text] [Related]
5. Differential glycosylation of polymeric and monomeric IgA: a possible role in glomerular inflammation in IgA nephropathy.
Oortwijn BD; Roos A; Royle L; van Gijlswijk-Janssen DJ; Faber-Krol MC; Eijgenraam JW; Dwek RA; Daha MR; Rudd PM; van Kooten C
J Am Soc Nephrol; 2006 Dec; 17(12):3529-39. PubMed ID: 17050773
[TBL] [Abstract][Full Text] [Related]
6. Role of IgA receptors in the pathogenesis of IgA nephropathy.
Lechner SM; Papista C; Chemouny JM; Berthelot L; Monteiro RC
J Nephrol; 2016 Feb; 29(1):5-11. PubMed ID: 26572664
[TBL] [Abstract][Full Text] [Related]
7. Injection of recombinant FcalphaRI/CD89 in mice does not induce mesangial IgA deposition.
van der Boog PJ; van Kooten C; van Zandbergen G; Klar-Mohamad N; Oortwijn B; Bos NA; van Remoortere A; Hokke CH; de Fijter JW; Daha MR
Nephrol Dial Transplant; 2004 Nov; 19(11):2729-36. PubMed ID: 15340093
[TBL] [Abstract][Full Text] [Related]
8. Gluten exacerbates IgA nephropathy in humanized mice through gliadin-CD89 interaction.
Papista C; Lechner S; Ben Mkaddem S; LeStang MB; Abbad L; Bex-Coudrat J; Pillebout E; Chemouny JM; Jablonski M; Flamant M; Daugas E; Vrtovsnik F; Yiangou M; Berthelot L; Monteiro RC
Kidney Int; 2015 Aug; 88(2):276-85. PubMed ID: 25807036
[TBL] [Abstract][Full Text] [Related]
9. Absence of CD89, polymeric immunoglobulin receptor, and asialoglycoprotein receptor on human mesangial cells.
Leung JCK; Tsang AWL; Chan DTM; Lai KN
J Am Soc Nephrol; 2000 Feb; 11(2):241-249. PubMed ID: 10665931
[TBL] [Abstract][Full Text] [Related]
10. Polymeric IgA increases the synthesis of macrophage migration inhibitory factor by human mesangial cells in IgA nephropathy.
Leung JC; Tang SC; Chan LY; Tsang AW; Lan HY; Lai KN
Nephrol Dial Transplant; 2003 Jan; 18(1):36-45. PubMed ID: 12480958
[TBL] [Abstract][Full Text] [Related]
11. Murine Models of Human IgA Nephropathy.
Suzuki H; Suzuki Y
Semin Nephrol; 2018 Sep; 38(5):513-520. PubMed ID: 30177023
[TBL] [Abstract][Full Text] [Related]
12. Fcalpha receptor (CD89) mediates the development of immunoglobulin A (IgA) nephropathy (Berger's disease). Evidence for pathogenic soluble receptor-Iga complexes in patients and CD89 transgenic mice.
Launay P; Grossetête B; Arcos-Fajardo M; Gaudin E; Torres SP; Beaudoin L; Patey-Mariaud de Serre N; Lehuen A; Monteiro RC
J Exp Med; 2000 Jun; 191(11):1999-2009. PubMed ID: 10839814
[TBL] [Abstract][Full Text] [Related]
13. Both IgA nephropathy and alcoholic cirrhosis feature abnormally glycosylated IgA1 and soluble CD89-IgA and IgG-IgA complexes: common mechanisms for distinct diseases.
Tissandié E; Morelle W; Berthelot L; Vrtovsnik F; Daugas E; Walker F; Lebrec D; Trawalé JM; Francoz C; Durand F; Moura IC; Paradis V; Moreau R; Monteiro RC
Kidney Int; 2011 Dec; 80(12):1352-63. PubMed ID: 21866091
[TBL] [Abstract][Full Text] [Related]
14. Pathogenic significance of IgA receptor interactions in IgA nephropathy.
Monteiro RC; Moura IC; Launay P; Tsuge T; Haddad E; Benhamou M; Cooper MD; Arcos-Fajardo M
Trends Mol Med; 2002 Oct; 8(10):464-8. PubMed ID: 12383768
[TBL] [Abstract][Full Text] [Related]
15. Interactions of human mesangial cells with IgA and IgA-containing immune complexes.
Novak J; Vu HL; Novak L; Julian BA; Mestecky J; Tomana M
Kidney Int; 2002 Aug; 62(2):465-75. PubMed ID: 12110007
[TBL] [Abstract][Full Text] [Related]
16. Binding of dimeric and polymeric IgA to rat renal mesangial cells enhances the release of interleukin 6.
van den Dobbelsteen ME; van der Woude FJ; Schroeijers WE; van den Wall Bake AW; van Es LA; Daha MR
Kidney Int; 1994 Aug; 46(2):512-9. PubMed ID: 7967365
[TBL] [Abstract][Full Text] [Related]
17. Association of soluble CD89 levels with disease progression but not susceptibility in IgA nephropathy.
Vuong MT; Hahn-Zoric M; Lundberg S; Gunnarsson I; van Kooten C; Wramner L; Seddighzadeh M; Fernström A; Hanson LÅ; Do LT; Jacobson SH; Padyukov L
Kidney Int; 2010 Dec; 78(12):1281-7. PubMed ID: 20811333
[TBL] [Abstract][Full Text] [Related]
18. Soluble CD89 is a critical factor for mesangial proliferation in childhood IgA nephropathy.
Cambier A; Gleeson PJ; Abbad L; Canesi F; da Silva J; Bex-Coudrat J; Deschênes G; Boyer O; Rabant M; Ulinski T; Hogan J; Peuchmaur M; Berthelot L; Monteiro RC
Kidney Int; 2022 Feb; 101(2):274-287. PubMed ID: 34756952
[TBL] [Abstract][Full Text] [Related]
19. Monomeric and polymeric IgA show a similar association with the myeloid FcalphaRI/CD89.
Oortwijn BD; Roos A; van der Boog PJ; Klar-Mohamad N; van Remoortere A; Deelder AM; Daha MR; van Kooten C
Mol Immunol; 2007 Feb; 44(5):966-73. PubMed ID: 16675016
[TBL] [Abstract][Full Text] [Related]
20. Immune complex formation in IgA nephropathy: CD89 a 'saint' or a 'sinner'?
Boyd JK; Barratt J
Kidney Int; 2010 Dec; 78(12):1211-3. PubMed ID: 21116273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
